MyoCell
Phase 2- Indications
- Chronic heart failure
Company intelligence / Profile preview
US Stem Cell Clinic, LLC
Sunrise, Florida, United Statesus-stemcell.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
The company faced FDA enforcement action for marketing unapproved stem cell treatments. The FDA characterized their SVF product as adulterated and misbranded drugs, and the Eleventh Circuit affirmed FDA's regulatory authority over their procedures.
- Therapeutic areas
- PulmonologyEndocrinologyImmunologyRheumatologyGastroenterologyCardiovascularNeurology
- Modalities
- Stem Cell TherapyStromal Vascular Fraction (SVF)Adipose-derived Stem Cells
- Industry
- Non-Academic Healthcare
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on US Stem Cell Clinic, LLC.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on US Stem Cell Clinic, LLC.